...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Apabetalone publication in "Current Opinion in Nephrology & Hypertension"

That's seems about par for the course in terms of Resverlogix's communications if history is any judge...'hey, let's tweet about an article that's over a month old'

Share
New Message
Please login to post a reply